Compare · HEXO vs RVLP
HEXO vs RVLP
Side-by-side comparison of HEXO Corp. (HEXO) and RVL Pharmaceuticals plc (RVLP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HEXO and RVLP operate in Pharmaceuticals and Biotechnology (Health Care), so they compete in similar markets.
- HEXO is the larger of the two at $176.3M, about 2.0x RVLP ($90.0M).
- HEXO has more recent analyst coverage (11 ratings vs 2 for RVLP).
- Company
- HEXO Corp.
- RVL Pharmaceuticals plc
- Price
- $0.70+3.98%
- $0.03-29.51%
- Market cap
- $176.3M
- $90.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Pharmaceuticals and Biotechnology
- Pharmaceuticals and Biotechnology
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 0
- 0
- Recent ratings
- 11
- 2
HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
RVL Pharmaceuticals plc
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Latest HEXO
- Cash Flow Chronicles: Analyst Dissects Canadian Cannabis Balance Sheets, Market Trends Vs. The US
- EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024
- SEC Form 15-12G filed by HEXO Corp.
- 'North Carolina Senate Approves Medical Marijuana Regulatory Appointment As House Leader Says 'Heavy-Handed' Tactics Not Helping Legalization's Fate' - Marijuana Moment
- 'Major Marijuana Industry Players Launch Super Pac To Advance Cannabis Reform As 2024 Election Heats Up' - Marijuana Moment
- 'Schumer Touts Marijuana Banking Bill As Bipartisan Priority, And Republican Sponsor Is Optimistic As Long As Measure Isn't Expanded' -Marijuana Moment Report
- Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost
- SEC Form 25-NSE filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
- SEC Form F-10POS filed by HEXO Corp.
Latest RVLP
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Other Events
- RVL Pharmaceuticals plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)
- RVL Pharmaceuticals plc filed SEC Form 8-K: Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits
- SEC Form 25-NSE filed by RVL Pharmaceuticals plc
- SEC Form DEF 14A filed by RVL Pharmaceuticals plc
- SEC Form PRE 14A filed by RVL Pharmaceuticals plc
- RVL Pharmaceuticals plc filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form SC 13D/A filed by RVL Pharmaceuticals plc (Amendment)